Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Cardiovascular Prevention
100%
Omega-3 Fatty Acids
100%
Secondary Prevention of Cardiovascular Diseases
100%
N-3 LC-PUFA
100%
Randomized Controlled Trial
86%
α-linolenic Acid
66%
Coronary Heart Disease Events
33%
Risk of Bias
26%
Coronary Heart Disease Mortality
26%
Arrhythmia
26%
Sensitivity Analysis
20%
All-cause Mortality
20%
Cardiovascular Health
20%
Cardiovascular Mortality
20%
Docosahexaenoic Acid
20%
CVD Events
20%
Eicosapentaenoic Acid
20%
Meta-analysis
13%
Meta-regression
13%
Risk Reduction
13%
Event Risk
13%
Lipids
13%
Adiposity
13%
Omega-3
13%
Cardiovascular Risk
6%
Placebo
6%
High Risk
6%
Review Update
6%
MEDLINE
6%
Cardiovascular Events
6%
Embase
6%
Review Authors
6%
Subgrouping
6%
World Health Organization
6%
Triglycerides
6%
Plant-based
6%
Dietary Advice
6%
Serious Adverse Events
6%
Random Effects
6%
High-income Countries
6%
Dose-response Relationship
6%
Oily Fish
6%
Funnel Plot
6%
N-3 Polyunsaturated Fatty Acids
6%
Increased Intake
6%
Omega-3 Supplements
6%
Omega-3 Fats
6%
Dependant
6%
Arrhythmic Risk
6%
Clinical Trial Registry
6%
Outcome Effect
6%
International Clinical Trials
6%
CVD Mortality
6%
Enriched Foods
6%
Duration of Effect
6%
Traditional Diet
6%
Extracted Data
6%
Cardiovascular Risk Factors
6%
Dose-dependent
6%
Health Evidence
6%
Pharmacology, Toxicology and Pharmaceutical Science
Omega-3 Fatty Acid
100%
Cardiovascular Disease
100%
Randomized Controlled Trial
65%
Linolenic Acid
50%
Ischemic Heart Disease
45%
Heart Arrhythmia
25%
All Cause Mortality
15%
Docosahexaenoic Acid
15%
Icosapentaenoic Acid
15%
Cardiovascular Mortality
10%
Cerebrovascular Accident
10%
Lipid
10%
Adverse Event
5%
Placebo
5%
Cardiovascular Risk
5%
Dose-Response Relationship
5%
Clinical Trial
5%
Triacylglycerol
5%